UMIN ID: UMIN000000978
Registered date:09/01/2008
Phase I study of Docetaxel, Cisplatin and S-1 in patients with advanced or recurrent gastric cancer
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Gastric cancer |
| Date of first enrollment | 2007/05/01 |
| Target sample size | 18 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Docetaxel 20-40mg/m2 Cisplatin 60mg/m2 S-1 80mg/m2 |
Outcome(s)
| Primary Outcome | Safety |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1. Active infection 2. Severe peritoneal metastasis 3. Massive pleural effusion 4. CNS metastasis 5. Severe diarrhea 6. Suspected of Interstitial Pneumonitis 7. Other severe complications 8. Active malignancy 9. Pregnant |
Related Information
| Primary Sponsor | Shizuoka Cancer Center |
|---|---|
| Secondary Sponsor | Aichi Cancer Center Central Hospital |
| Source(s) of Monetary Support | none |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Shuichi Hironaka |
| Address | 1007 Shimonagakubo Nagaizumi Sunto-gun Shizuoka 411-8777, Japan Japan |
| Telephone | 055-989-5222 |
| s.hironaka@scchr.jp | |
| Affiliation | Shizuoka Cancer Center Division of Gastrointestinal Oncology |
| scientific contact | |
| Name | Shuichi Hironaka |
| Address | 1007 Shimonagakubo Nagaizumi Sunto-gun Shizuoka 411-8777, Japan Japan |
| Telephone | 055-989-5222 |
| Affiliation | Shizuoka Cancer Center Division of Gastrointestinal Oncology |